PIK3CA and cancer: Driver mutations such as frameshifts mutations in TP53 and MAP3K1 genes or missense mutations in the PIK3CA gene can generate tumour neoantigens, suggesting that a T cell-mediated immune response, if present and properly validated, would target all cancer cells15,27,28.